GENMAB HOLDING B.V.

City:

Utrecht

Country:

Netherlands

Published Applications:

Last publication date:

2024-03-07

Patent Grants:

Last grant date:

2026-03-17

Top Inventors for applications by GENMAB HOLDING B.V.

These are the the leading inventors for applications assigned to GENMAB HOLDING B.V.:

Hilma VAN DER HORST 6 Utrecht, Netherlands
Tuna MUTIS 6 Amsterdam, Netherlands
Margaret LINDORFER 6 Keswick, VA United States
Simone OOSTINDIE 6 Utrecht, Netherlands

Frank Beurskens 6 Utrecht, Netherlands
Esther BREIJ 6 Utrecht, Netherlands
Ronald TAYLOR 6 Keswick, VA United States
Paul Parren 6 Odijk, Netherlands

Edward van den Brink 5 Utrecht, Netherlands
Andreas HOLLENSTEIN 5 Utrecht, Netherlands
Marije Overdijk 5 Utrecht, Netherlands
Martine E. D. CHAMULEAU 5 Amsterdam, Netherlands

Martine E.D. CHAMULEAU 5 Amsterdam, Netherlands

Recent patent applications by GENMAB HOLDING B.V.

GENMAB HOLDING B.V. based in Utrecht, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-03-07 ✅ Patent 12,577,316 granted on 2026-03-17

US20240076397A1

Chemistry; metallurgy

BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF

#2 | 2022-08-11 ✅ Patent 12,448,459 granted on 2025-10-21

US20220251231A1

Chemistry; metallurgy

BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF

#3 | 2021-12-02 ✅ Patent 12,275,797 granted on 2025-04-15

US20210371539A1

Chemistry; metallurgy

Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereof

#4 | 2021-11-18 ✅ Patent 11,396,553 granted on 2022-07-26

US20210355232A1

Chemistry; metallurgy

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

#5 | 2021-01-28 ✅ Patent 11,034,772 granted on 2021-06-15

US20210024647A1

Chemistry; metallurgy

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

#6 | 2020-09-17 ✅ Patent 11,512,137 granted on 2022-11-29

US20200291124A1

Chemistry; metallurgy

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof

Also check out GENMAB HOLDING B.V.'s (Utrecht, Netherlands) applicant profile with 8 patent applications submitted.

AssigneeID:

383213 ⎘